微乳液高效液相色谱的发展与应用

综述了过去十年中微乳液高效液相色谱法的发展与应用,主要涉及溶质的迁移行为及其影响因素和微乳液高效液相色谱在药物分析中的应用(引用文献33篇)。     

药物分析

本文对国内药物分析在１９９３－１９９５年间的主要进展作了评述。内容包括下述方法在药物分析中的应用：分光光度法、高效液相色谱法、气相色谱法、薄层色谱法、电化学分析法和其它方法等。共引用文献７６１篇。     

蛋白质顺序测定技术(六)

七、高效液相色谱法在蛋白质、肽、氨基酸衍生物分离鉴定中的应用高效液相色谱法(简称HPLC)已成为当前最有用的分离鉴定手段之一,在生物化学、药物化学、一般有机化学及高分子化学等领域都得到广泛的应用,在蛋白质及PTH-氨基酸的分离鉴定上也可收到良好的效果。     

天然酚、有机酸的高效液相色谱分析的进展

对近十年来高效液相色谱法在茶叶、葡萄酒、果汁、药物、化妆品等物质中天然酚、有机酸类化合物分析中的应用研究进行了详细评述(引用文献39篇)。     

高效液相色谱法对外消旋药物的拆分

综述了近年来高效液相色谱法在药物对映体拆分与测定中的应用，介绍了许多有代表性的具有不同药理性能对映异构体药物，并指出出拆份的重要意义，共引用文献３２篇。     

秋水仙碱分析方法的研究概述

针对秋水仙碱作为治疗急性痛风性关节炎药物的应用,综述了国内外秋水仙碱测量方法研究进展,重点介绍了伏安法、高效液相色谱法、高效液相色谱-质谱联用法等的研究情况.     

制备型高效液相色谱在天然产物分离中的应用

制备型高效液相色谱法在天然产物的分离纯化中得到广泛应用。从制备型高效液相色谱法的技术分类及其在天然产物研究中的实际应用方面对目前国内外制备型高效液相色谱技术研究现状进行了综述,对其发展动态进行了展望。     

现代仪器分析技术在荧光增白剂检测中的应用

综述了近10年光谱(包括紫外分光光度法、荧光分光光度法等)、色谱(包括高效液相色谱法、超高效液相色谱法、超高效合相色谱法)、质谱(包括液相色谱-串联质谱法、液相色谱-串联高分辨飞行时间质谱法)等现代仪器分析技术在荧光增白剂检测中的应用,并对其发展趋势进行了展望。     

药物分析(Ⅰ)

对国内药物分析在2002．1～2003．6的主要进展进行评述。内容包括分光光度法、高效液相色谱法、气相色谱法、薄层色谱法、毛细管电泳法和其它分析方法等.另外,着重对中药指纹图谱、手性药物拆分和高效液相色谱法联用技术等进行评述。共引用文献2211篇.     

药物分析（Ⅰ）

对国内药物分析在2005~2006年的主要进展进行评述。内容包括高效液相色谱法、气相色谱法、毛细管电泳法、薄层色谱法、分光光度法和其它分析方法等。另外,对高效液相色谱法和气相色谱法的不同联用技术进行分别评述。共引用文献3294篇。     

Demonstration of the capabilities of a parallel high performance liquid chromatography tandem mass spectrometry system for use in the analysis of drug discovery plasma samples.

There is a continuing need for increased throughput in the evaluation of new drug entities in terms of their pharmacokinetic (PK) parameters. This report describes an alternative procedure for increasing the throughput of plasma samples assayed in one overnight analysis: the use of parallel high performance liquid chromatography (HPLC) combined with tandem mass spectrometry (parallel LC/MS/MS). For this work, two HPLC systems were linked so that their combined effluent flowed into one tandem MS system. The parallel HPLC/APCI-MS/MS system consisted of two Waters 2690 Alliance systems (each one included an HPLC pump and an autosampler) and one Finnigan TSQ 7000 triple quadrupole mass spectrometer. Therefore, the simultaneous chromatographic separation of the plasma samples was carried out in parallel on two HPLC systems. The MS data system was able to deconvolute the data to calculate the results for the samples. Using this system, 20 compounds were tested in one overnight assay using the rapid rat PK screening model which includes a total of 10 standards plus samples and two solvent blanks per compound tested. This application provides an additional means of increasing throughput in the drug discovery PK assay arena; using this approach a two-fold increase in throughput can be achieved in the assay part of the drug discovery rat PK screening step.     

Determination of drug concentrations in plasma by a highly automated, generic and flexible protein precipitation and liquid chromatography/tandem mass spectrometry method applicable to the drug discovery environment

This report presents a highly automated procedure for the determination of drug concentrations in plasma samples. The method is generic, in that it has been applied without adaptation to many different drug candidate molecules, but is also flexible, in that variations in the nature and number of samples to be analyzed can be readily accommodated. The method includes preparation of dilutions of analyte stock solutions, spiking these into control plasma to generate analytical standards, and preparation of samples suitable for analysis by high-performance liquid chromatography/tandem mass spectrometry (HPLC/MS/MS) by precipitation of plasma proteins with acetonitrile, centrifugation, and dilution of the supernatants with HPLC buffer. All of these steps, apart from centrifugation, are performed without manual intervention on an automated liquid-handling workstation using 96-well plates. Analysis is by HPLC/MS/MS, using a generic HPLC gradient. Commercially available software was used for optimization of parameters for analysis by HPLC/MS/MS, integration of chromatographic peaks, and quantification of drug concentrations. The use of this methodology in our laboratory has greatly facilitated the analysis of small sample sets for a large number of analytes, a situation regularly encountered in an early drug discovery environment.     

Planar chromatography for drug residue screening in food applications

Summary Planar chromatography (PC) is of interest for veterinary drug screening. An example is given of the use of a PC screening method followed by a high performance liquid chromatographic (HPLC) method for confirmation of positives. The results for 300 samples were obtained in 14 days whereas the HPLC analysis alone would have required 50 days work. The future of PC in veterinary drug residue analysis as a screening method and also as confirmatory (quantitative) method is discussed.     

UHPLC: The Greening Face of Liquid Chromatography

Pharmaceutical analysis based on chromatographic separation is an important part of studies aimed at developing routine quality analysis of drugs. High-performance liquid chromatography (HPLC) is one of the main analytical techniques recommended for drug analysis. Although it meets many criteria vital for analysis, it is time-consuming and uses a relatively high amount of organic solvents compared to other analytical techniques. Recently, Ultra-high-performance liquid chromatography (UHPLC) has been frequently proposed as an alternative to HPLC, which means introducing an environment-friendly approach to drug analysis achieved by reducing the consumption of solvents. It also offers greater chromatographic resolution and higher sensitivity as well as requiring less time due to faster analysis. This review focuses on the basics of UHPLC, compares that technique with HPLC and discusses the possibilities of applying UHPLC for the analysis of different pharmaceuticals and biopharmaceuticals.

     

高效迎头分析法测定药物-人血清白蛋白混合液中游离药物浓度

 用高效迎头分析法 (HPFA)测定了药物 人血清白蛋白 (HSA)混合液中游离药物的浓度。样品溶液不经任何处理直接进样到装有内表面反相固定相的色谱柱中 ,用 67mmol/L磷酸盐缓冲液 ( pH 7 4 ,I =0 17mol/L)作流动相。当进样体积足够大时 ,游离药物以平顶峰的形式被洗脱出来 ,平顶峰区域洗脱液中的药物浓度等于样品溶液中游离药物的浓度。收集平顶峰区域的洗脱液 ,然后将一定体积的洗脱液注入到反相色谱柱中 ,测定游离药物的浓度。用该法测定酮基布洛芬 HSA和头孢哌酮 HSA两种混合液中游离药物的浓度。     

The analysis of basic pharmaceutical compounds by capillary electrochromatography using continuous bed stationary phase

Summary Capillary electrochromatography (CEC) is classed as a hybrid technique between CE and HPLC and it combines the advantages of both these techniques. However, in some cases the disadvantages are also brought to light and some of these are difficult to resolve. For example the analysis of basic compounds using CEC. The problems of tailing peaks during HPLC analysis of basic compounds was resolved by end capping the residual silanol groups, but in CEC these are the groups that generate the electroosmotic flow. The analysis of basic compounds is crucial within the pharmaceutical industry where a high percentage of the drug actives are basic. Specially designed Continuous Beds stationary phases (CB) can mean that each application can have a specific stationary phase. In order to overcome the problem associated with the analysis of basic compounds using electrochromatography, we have designed a CB stationary phase with a positive charge, which could be operated using negative voltage. The resulting chromatography showed almost gaussian peaks for bases like nortriptyline which tail significantly using stationary phase typically used in CEC.     

UHPLC: The Greening Face of Liquid Chromatography

Pharmaceutical analysis based on chromatographic separation is an important part of studies aimed at developing routine quality analysis of drugs. High-performance liquid chromatography (HPLC) is one of the main analytical techniques recommended for drug analysis. Although it meets many criteria vital for analysis, it is time-consuming and uses a relatively high amount of organic solvents compared to other analytical techniques. Recently, Ultra-high-performance liquid chromatography (UHPLC) has been frequently proposed as an alternative to HPLC, which means introducing an environment-friendly approach to drug analysis achieved by reducing the consumption of solvents. It also offers greater chromatographic resolution and higher sensitivity as well as requiring less time due to faster analysis. This review focuses on the basics of UHPLC, compares that technique with HPLC and discusses the possibilities of applying UHPLC for the analysis of different pharmaceuticals and biopharmaceuticals.     

Determination of Paeoniflorin in Total Glucosides of Peony Root by HPLC

The crude drug of Radix Paeoniae Alba has been used extensively in traditional Chinese medicine as an analgesic, an antispasmodic,an astringent, and a sedative for the treatment of a variety of painful afflictions. A modern way of using Radix Paeoniae Alba is the application of Total Glucosides of Peony Root (TGPR), which is the ethanol extract from the crude drug. Our interest in this work is to develop a method to determine one of the main effective components, Paeoniflorin, in TGPR by HPLC. Although several HPLC methods for the determination of Paeoniflorin were reported before,our method has the advantages of simplicity, rapidity and accuracy.     

Zirconia-based column high-performance liquid chromatography/atmospheric pressure photoionization tandem mass spectrometric analyses of drug molecules in rat plasma

A method using zirconia-based column high-performance liquid chromatography (HPLC) interfaced with an atmospheric pressure photoionization (APPI) source and a tandem mass spectrometer (MS/MS) was developed for the quantitative determination of new chemical entities in rat plasma in support of pharmacokinetics studies. The ionization suppression resulting from endogenous components of the biological matrices on the quantitative zirconia-based column HPLC/APPI-MS/MS method was investigated using the post-column infusion technique. The analytical results for 'rapid rat pharmacokinetics' for 12 drug discovery compounds, obtained by both silica-based phase (S-phase) and zirconia-based phase (Z-phase) chromatographic separation, are in good agreement in terms of accuracy. The application of a Z-phase column for high-temperature fast HPLC/MS/MS methods was explored to reduce the analysis time from 3 min to 30 s for column temperatures of 25-110 degrees C, respectively. The chromatographic retention times and peak responses of all analytes were found to be reproducible under high-temperature conditions following 100 continuous injections, with %CV less than 0.4 and 5, respectively.